COVID-19 preclinical drug development database
Read the letter from the Academy's President and Vice President, inviting researchers to contribute to this survey: https://acmedsci.ac.uk/file-download/63879858
Around the world researchers are driving forward research at an unprecedented pace to tackle the COVID-19 pandemic. This project will map the UK landscape of COVID-19 preclinical drug discovery research and development.
We aim to provide a comprehensive overview of research into developing novel therapeutic targets, new molecular entities and repurposing existing medicines.
By contributing to this database, you will support the COVID-19 research effort by enabling the UK research and funding community to quickly identify opportunities for collaboration, avoid duplication of effort and prioritise the most promising research.
We welcome and encourage contributions of a range of types from both academia and industry. We are interested in collating information on two main types of research: